Objective To duplicate the animal steatohepatitis model with fatrich and cholrich diet.
目的建立一个非酒精性脂肪肝动物模型。
Thiazolidinedione therapy for nonalcoholic steatohepatitis: Go, stop, or proceed with caution?
噻唑烷二酮治疗非酒精性脂肪肝炎：继续，停止还是小心前行？
Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials?
联合治疗应是未来非酒精性脂肪性肝炎临床试验的范例吗？
The new study included 55 people with nonalcoholic steatohepatitis and either insulin resistance or type 2 diabetes.
新的研究包括55个患非酒精性脂肪性肝炎且有胰岛素抵抗或2型糖尿病的患者。
Nonalcoholic steatohepatitis (NASH) is a chronic progressive liver disease that is strongly associated with obesity.
非酒精性脂肪肝炎(NASH)，是一种与肥胖相关的慢性进展性肝脏疾病。
Non-alcoholic steatohepatitis(NASH)is a chronic liver disease. It is known and thought highly from 1980s last century.
非酒精性脂肪性肝炎（NASH）是一种慢性肝脏疾病，自上世纪八十年代以来逐渐被认识并引起重视。
Objective: To study on the treatment of chrysalis oil for high-fat steatohepatitis in rats and its possible mechanisms.
目的：观察蚕蛹油对高脂诱导的脂肪性肝炎的治疗作用，并探讨其可能的作用机制。
Objective:To evaluate the clinical therapeutically effects of the Qingzhitang Decoction on Nonalcoholic steatohepatitis(NASH).
目的：观察中药清脂汤对非酒精性脂肪肝（NASH）的临床疗效。
Frequent nocturnal hypoxic episodes in patients with obstructive sleep apnea were a risk factor for developing steatohepatitis.
阻塞性睡眠呼吸暂停患者频繁的夜间间歇低氧是产生脂肪性肝炎的危险因素。
Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).
【译】适度饮酒与非酒精性脂肪肝患者脂肪肝(NAFLD)的患病率下降有关的。
Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis.
脂肪性肝病恶化后会很复杂，最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。
We know that 20% of those nonalcoholic fatty liver disease patients will go on to progress to a condition called NASH, which is nonalcoholic Steatohepatitis.
而20%的非酒精性脂肪肝的患者会进展为非酒精性脂肪型肝炎(简称NASH)。
Method Serum PON1 activity was measured by using paraoxon as substrate in 30 case of norm, 52 of simple fatty liver, 41 of steatohepatitis and 31 of fatty liver cirrhosis.
方法以对氧磷为底物测定30例正常人、52单纯性脂肪肝患者、41例脂肪性肝炎患者、31例脂肪性肝硬化患者血清pon1活性。
I think that it probably has to do with the fact that the pathogenesis of all patients with non-alcoholic steatohepatitis, is probably not a single way or a single pathway.
我们必须认识到所有非酒精性脂肪性肝炎患者发病机制并不是单一的信号途径。
Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis. NAFLD can lead to liver failure.
脂肪性肝病恶化后会很复杂，最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。非酒精性脂肪肝会导致肝功能衰竭。
Objective to study the influence of maize oil on lipidic metabolization in rats 'liver and probe into the role and pathogenesis of single maize oil in the occurrence of Steatohepatitis.
目的：研究玉米油对大鼠肝脏脂质代谢的影响，探讨单纯玉米油在脂肪性肝炎形成中的作用及其机制。
Conclusions single 20% maize oil can injure the female rats liver cell and lead to the fatty liver and steatohepatitis, hyperplasia of fibre tissue in liver if prolonging the feeding time.
结论：单纯20%玉米油可以使雌性大鼠肝细胞受到损伤，导致雌性大鼠脂肪肝与脂肪性肝炎形成，延长食用时间肝脏有纤维组织增生。
Nonalcoholic fatty liver disease(NAFLD) is a kind of chronic liver disease, whose spectrum of the disease includes simple hepar adiposum, steatohepatitis(NASH), hepatic fibrosis, and cirrhosis.
非乙醇性脂肪性肝病（NAFLD）是一种常见的慢性肝病，其疾病谱包括单纯性脂肪肝、非乙醇性脂肪性肝炎（NASH）、肝纤维化及肝硬化。
Fatty liver disease (FLD) is a clinicopathological syndrome caused by a variety of reasons. The main lesions are in hepatic lobule with steatohepatitis and accumulation of triglycerides in the liver.
脂肪性肝病是多种原因引起的病变主体在肝小叶、以肝细胞脂肪变性和脂肪蓄积过多为主的临床病理综合征。
The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.
非酒精性脂肪性肝炎和其他脂肪性肝病的发病机制：四步模型，包括肝硬化进展的脂质释放和肝微梗阻的作用。
The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.
非酒精性脂肪性肝炎和其他脂肪性肝病的发病机制：四步模型，包括肝硬化进展的脂质释放和肝微梗阻的作用。
应用推荐